Rapid technological advances in compiling and analysing big datasets of genetic information have allowed large-scale genomic projects to begin to identify and characterize the molecular causes of autism. Technological progress in genomics and in neurodevelopmental biology have opened up the possibility to improve medical care by allowing earlier intervention and by promoting care based on individual genotypes. These advances have implications for  healthcare systems and healthcare delivery. Policy-makers can anticipate the need for particular healthcare services by understanding the directions and ramifications of this new type of autism research.

About Harry

Harry Doernberg graduated with a B.S. in Molecular Biophysics and Biochemistry from Yale and is currently enrolled as a Masters of Music student in cello performance at the Yale School of Music. He has worked widely in the special-needs community for almost half of his life and helps instruct the "Autism and Related Disorders Class" at Yale with Dr. Fred Volkmar, author of the DSM-IV sections for developmental delays. Harry aims to be a physician who has a practice that caters to adults with special needs.